Content about Alcohols

October 22, 2012
Watson, Actavis divest more drugs as condition for FTC merger approval

Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.

NEW YORK – Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.

October 9, 2012
NewsBytes — Chain Pharmacy, 10/15/12

Drug maker Dr. Reddy’s Labs has launched a generic antibiotic drug, the company said. The India-based company announced the launch of amoxicillin tablets, capsules and oral suspension.

Dr. Reddy's launches antibiotics

September 24, 2012
Purdue Pharma's RxPatrol provides Twitter updates on pharmacy crime

Pharmacy staff, law-enforcement officials and loss-prevention personnel can follow updates about pharmacy robberies, burglaries and potential threats in their area through Twitter updates by a drug maker that developed a program to combat pharmacy crime.

STAMFORD, Conn. — Pharmacy staff, law enforcement officials and loss-prevention personnel can follow updates about pharmacy robberies, burglaries and potential threats in their area through Twitter updates by a drug maker that developed a program to combat pharmacy crime.

September 19, 2012
Schiff launching Move Free One, a joint supplement formulated with krill oil

Schiff is in the process of launching its latest Move Free joint supplement — Move Free One — which combines hyaluronic acid and astaxanthin with krill oil, the source of omega-3 for its Mega Red brand.

SALT LAKE CITY, Utah — Schiff is in the process of launching its latest Move Free joint supplement — Move Free One — which combines hyaluronic acid and astaxanthin with krill oil, the source of omega-3 for its Mega Red brand.

September 18, 2012
BI launches Combivent Respimat

Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

RIDGEFIELD, Conn. — Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

BI Pharmaceuticals announced the launch of Combivent Respimat (ipratropium bromide and albuterol), calling it a propellant-free inhaler that uses a slow-moving mist to deliver the same active ingredients as the Combivent metered dose inhaler, requiring one inhalation per dose, compared with Combivent MDI's two inhalations.

September 18, 2012
Study: Majority of critically ill children have low vitamin D blood levels

A recent study published in the journal Pediatrics determined that 3-out-of-4 critically ill children were found to have vitamin D blood levels below the target considered safe by many experts and medical societies.

 OTTAWA, Canada — A recent study published in the journal Pediatrics determined that 3-out-of-4 critically ill children were found to have vitamin D blood levels below the target considered safe by many experts and medical societies. 

"This is the first study to report on vitamin D levels in a large group of critically ill children," stated Dayre McNally, lead researcher and a clinical researcher and intensivist at the Children's Hospital of Eastern Ontario.

September 11, 2012
Dr. Reddy's launches generic hypertension pill

Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

HYDERABAD, India — Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

Dr. Reddy's announced the launch of metoprolol succinate extended-release tablets in the 25-mg, 50-mg, 100-mg and 200-mg strengths. The drug will be available in bottle counts of 100 and 500.

The drug is a generic version of AstraZeneca's Toprol-XL, branded and generic versions of which had sales of about $1.13 billion during the 12-month period that ended in June, according to IMS Health.

September 7, 2012
Perrigo seeks approval for generic bronchospasm drug

Perrigo is seeking regulatory approval for what it called the first generic version of a drug for treating bronchospasm.

ALLEGAN, Mich. — Perrigo is seeking regulatory approval for what it called the first generic version of a drug for treating bronchospasm.

September 4, 2012
FDA's Nonprescription Drugs Advisory Committee to meet on Oxytrol Rx-to-OTC switch

According to a Food and Drug Administration post Friday, the FDA's Nonprescription Drugs Advisory Committee will be meeting Nov. 9 regarding the partial switch application from prescription to over the counter of Oxytrol (oxybutynin transdermal system), as submitted by MSD Consumer.

SILVER SPRING, Md. — According to a Food and Drug Administration post Friday, the FDA's Nonprescription Drugs Advisory Committee will be meeting Nov. 9 regarding the partial switch application from prescription to over the counter of Oxytrol (oxybutynin transdermal system) submitted by MSD Consumer. The proposed OTC product would be called Oxytrol for Women and would be indicated for the treatment of overactive bladder in women.

The prescription form of Oxytrol is licensed by Watson Pharma.

August 21, 2012
FDA approves opioid addiction treatment

The Food and Drug Administration has approved a drug made by Reckitt Benckiser Pharmaceuticals for treating addiction to opioid drugs, the drug maker said.

RICHMOND, Va. — The Food and Drug Administration has approved a drug made by Reckitt Benckiser Pharmaceuticals for treating addiction to opioid drugs, the drug maker said.

Reckitt Benckiser announced the approval of Suboxone (buprenorphine and naloxone) sublingual film in the 4 mg and 12 mg strengths, used for the maintenance treatment of dependence on prescription opioid painkillers and heroin. Addiction to opioid drugs is a growing epidemic in the United States, the company said.

May 31, 2012
Tris Pharma, Perrigo to bring Delsym generic equivalent to market

Tris Pharma on Thursday announced that the Food and Drug Administration has approved its generic equivalent to Reckitt Benckiser's Delsym, an extended-release oral liquid suspension containing dextromethorphan.

MONMOUTH JUNCTION, N.J. — Tris Pharma on Thursday announced that the Food and Drug Administration has approved its generic equivalent to Reckitt Benckiser's Delsym, an extended-release oral liquid suspension containing dextromethorphan.

May 1, 2012
Maty's launches chest rub at Walmart

Maty's Healthy Products on Monday launched its all-natural baby chest rub into select Walmart stores, the company announced.

PITTSFORD, N.Y. — Maty's Healthy Products on Monday launched its all-natural baby chest rub into select Walmart stores, the company announced.

"Having one of our products available at such a highly recognized and widely celebrated retailer like Walmart is a huge step for our brand," Maty's co-founder Robert Harrington said.

March 5, 2012
Hisamitsu America launches trio of topical pain relief solutions

Hisamitsu America on Monday launched three new analgesic patches, the company stated.

FLORHAM PARK, N.J. — Hisamitsu America on Monday launched three new topical analgesic solutions, the company stated.

February 29, 2012
Aroma Naturals launches skin care line

Aroma Naturals, a maker of all-natural candles, is launching a new skin care line comprised of beauty oils, body oils and body butters.

CERRITOS, Calif. — Aroma Naturals, a maker of all-natural candles, is launching a new skin care line comprised of beauty oils, body oils and body butters.

The new beauty oils come in three aromas: Orange honey blossom, Lavender passion flower, and superfruit passion fruit.

The body oils come in three different aromas: Tea tree eucalyptus, coconut and vanilla blossom, and menthol icy hot herbs. Each oil also serves to help ease difficulties with various physical ailments, such as breathing problems and sore muscles.

February 29, 2012
Murad develops new Time Release retinol concentrate for deep wrinkles

Murad, whose products are sold at salons, spas, Sephora and Ulta, is bringing to market in March its new Time Release retinol concentrate for deep wrinkles, featuring new technology that is designed to control the release of retinol over time for maximum performance while improving the stability and efficacy of the product.

EL SEGUNDO, Calif. — Murad, whose products are sold at salons, spas, Sephora and Ulta, is bringing to market in March its new Time Release retinol concentrate for deep wrinkles, featuring new technology that is designed to control the release of retinol over time for maximum performance while improving the stability and efficacy of the product.

November 28, 2011
Performance Health introduces Perform Pain Relieving Spray

Performance Health announced the availability of Perform Pain Relieving Spray, a solution for applying cold therapy to hard-to-reach areas.

AKRON, Ohio — Performance Health announced the availability of Perform Pain Relieving Spray, a solution for applying cold therapy to hard-to-reach areas.

July 5, 2011
Brushing on innovation

L’Oréal Paris has combined its cosmetics and skin care expertise into one innovative formula with Visible Lift Smooth Absolute instant age-reversing foundation.


NEW YORK — L’Oréal Paris has combined its cosmetics and skin care expertise into one innovative formula with Visible Lift Smooth Absolute instant age-reversing foundation.


The SPF 17 formula is infused with an anti-aging complex, hydra-collagen, which also contains Pro-Retinol A, elastic, collagen and vitamin E. The prestige-inspired, click-through brush sweeps the formula evenly onto skin, providing controllable coverage and a weightless finish.


February 18, 2011
Gel, spray know how to ‘Stopain’

HAZLETON, Pa. — Troy Healthcare in January acquired the distribution of its Stopain brand, an external analgesic Troy has been manufacturing since 2002 that is already an up-and-coming pain-relief spray. The brand cracked the top 10 list of external analgesic rubs for the 12 weeks ended Dec. 26, 2010, moving into the No. 10 spot with $1.3 million in sales across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data. SKU growth of 16.1% in that period also is outpacing category growth of 11.3%.


January 5, 2011
Troy Healthcare buys Stopain, announces line extension

Troy Healthcare on Wednesday announced its purchase of the Stopain brand from DRJ Group and also stated that a new Stopain gel line extension will be shipping to stores in early 2011.

HAZELTON, Pa. — Troy Healthcare on Wednesday announced its purchase of the Stopain brand from DRJ Group and also stated that a new Stopain gel line extension will be shipping to stores in early 2011.

April 12, 2010
FDA to begin removing inhalers containing CFC propellants from market

The Food and Drug Administration will start phasing out asthma and chronic obstructive pulmonary disease...

SILVER SPRING, Md. The Food and Drug Administration will start phasing out asthma and chronic obstructive pulmonary disease inhalers that contain ozone-depleting chlorofluorocarbons in less than two months, the agency announced Tuesday.

 

March 23, 2010
Bodycology rolls out body washes at Walgreens

Advanced Beauty Systems is expanding its Bodycology brand portfolio with the launch of its new...

February 23, 2010
Study finds Ulesfia effectively kills head lice

A new non-neurotoxic treatment for head lice has been found to have an average of...

HOBOKEN, N.J. A new non-neurotoxic treatment for head lice has been found to have an average of 91.2% treatment success rate after one week, and to be safe in humans from 6 months of age and up, according to a study published in the latest issue of Pediatric Dermatology.